| Edoxaban for the treatment of cancer-associated venous thromboembolism GE Raskob, N Van Es, P Verhamme, M Carrier, M Di Nisio, D Garcia, ... New England Journal of Medicine 378 (7), 615-624, 2018 | 1688 | 2018 |
| A consensus review on malignancy‐associated hemophagocytic lymphohistiocytosis in adults N Daver, K McClain, CE Allen, SA Parikh, Z Otrock, C Rojas‐Hernandez, ... Cancer 123 (17), 3229-3240, 2017 | 209 | 2017 |
| Clinical impact of bleeding in cancer-associated venous thromboembolism: results from the Hokusai VTE cancer study N Kraaijpoel, M Di Nisio, FI Mulder, N Van Es, J Beyer-Westendorf, ... Thrombosis and haemostasis 118 (08), 1439-1449, 2018 | 196 | 2018 |
| Clinical, epidemiological and microbiological characteristics of a cohort of pulmonary tuberculosis patients in Cali, Colombia CM Rojas, SL Villegas, HM Piñeros, EM Chamorro, CE Durán, ... Biomedica 30 (4), 478-481, 2010 | 55* | 2010 |
| Hematologic complications of immune checkpoint inhibitors MH Kroll, C Rojas-Hernandez, C Yee Blood, The Journal of the American Society of Hematology 139 (25), 3594-3604, 2022 | 53 | 2022 |
| Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: a … JA Ross, MM Miller, CMR Hernandez Thrombosis Research 150, 86-89, 2017 | 53 | 2017 |
| Advances in mechanisms, diagnosis, and treatment of pernicious anemia CMR Hernandez, TH Oo Discovery medicine 19 (104), 159-168, 2015 | 45 | 2015 |
| Chronic Epstein Barr virus infection leading to classical Hodgkin lymphoma NM Sarwari, JD Khoury, CMR Hernandez BMC hematology 16, 1-6, 2016 | 42 | 2016 |
| Hemolytic uremic syndrome associated with Escherichia coli O157:H7 infection in older adults: a case report and review of the literature H Ko, H Maymani, C Rojas-Hernandez Journal of Medical Case Reports 10, 1-4, 2016 | 38 | 2016 |
| Challenging clinical presentations of pernicious anemia. TH Oo, CM Rojas-Hernandez Discovery Medicine 24 (131), 107-115, 2017 | 37 | 2017 |
| The novel oral anticoagulants CM Rojas-Hernandez, DA Garcia Seminars in thrombosis and hemostasis 39 (02), 117-126, 2013 | 34 | 2013 |
| Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors N Abdel-Wahab, JH Tayar, F Fa'ak, G Sharma, MA Lopez-Olivo, A Yousif, ... Blood Advances 4 (8), 1746-1755, 2020 | 30 | 2020 |
| Phase II trial of sorafenib in combination with capecitabine in patients with hepatocellular carcinoma: INST 08‐20 Y Patt, C Rojas‐Hernandez, HM Fekrazad, P Bansal, FC Lee The Oncologist 22 (10), 1158-e116, 2017 | 27 | 2017 |
| Management of immune-mediated cytopenias in the era of cancer immunotherapy: a report of 4 cases Y Sun, SK Lee, TH Oo, CM Rojas-Hernandez Journal of Immunotherapy 41 (1), 32-34, 2018 | 24 | 2018 |
| Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: Challenging issues in the care of patients regarding cancer-associated thrombosis (CAT) N Tsoukalas, N Brito-Dellan, C Font, T Butler, CM Rojas-Hernandez, ... Supportive Care in Cancer 30 (10), 8559-8573, 2022 | 19 | 2022 |
| Poor performance of D-dimer in excluding venous thromboembolism among patients with lymphoma and leukemia A Qdaisat, R Al Soud, CC Wu, CMR Hernandez, J Li, QH Meng, ... Haematologica 104 (6), e265, 2019 | 18 | 2019 |
| Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis CM Rojas-Hernandez, TH Oo, HA García-Perdomo Journal of thrombosis and thrombolysis 43, 233-240, 2017 | 18 | 2017 |
| Nivolumab-induced cold agglutinin syndrome successfully treated with rituximab M Hasanov, SN Konoplev, CMR Hernandez Blood advances 2 (15), 1865-1868, 2018 | 17 | 2018 |
| Role of vena cava filters for the management of cancer-related venous thromboembolism: systematic review and meta-analysis CM Rojas-Hernandez, JA Zapata-Copete, HA García-Perdomo Critical Reviews in Oncology/Hematology 130, 44-50, 2018 | 16 | 2018 |
| Management and outcomes of hematological immune-related adverse events: systematic review and meta-analysis NR Wilson, JR Lockhart, HA Garcia-Perdomo, TH Oo, ... Journal of Immunotherapy 45 (1), 13-24, 2022 | 15 | 2022 |
